These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 33399865)

  • 1. Impact of biological sex on cryptococcal meningitis mortality in Uganda and South Africa.
    Stadelman AM; Ssebambulidde K; Tugume L; Pastick KA; Hullsiek KH; Lofgren S; Nuwagira E; Evans EE; Williams DA; Muzoora C; Meya DB; Rajasingham R; Rhein J; Boulware DR
    Med Mycol; 2021 Jul; 59(7):712-719. PubMed ID: 33399865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determinants of mortality in a combined cohort of 501 patients with HIV-associated Cryptococcal meningitis: implications for improving outcomes.
    Jarvis JN; Bicanic T; Loyse A; Namarika D; Jackson A; Nussbaum JC; Longley N; Muzoora C; Phulusa J; Taseera K; Kanyembe C; Wilson D; Hosseinipour MC; Brouwer AE; Limmathurotsakul D; White N; van der Horst C; Wood R; Meintjes G; Bradley J; Jaffar S; Harrison T
    Clin Infect Dis; 2014 Mar; 58(5):736-45. PubMed ID: 24319084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic implications of baseline anaemia and changes in haemoglobin concentrations with amphotericin B therapy for cryptococcal meningitis.
    Tugume L; Morawski BM; Abassi M; Bahr NC; Kiggundu R; Nabeta HW; Hullsiek KH; Taseera K; Musubire AK; Schutz C; Muzoora C; Williams DA; Rolfes MA; Meintjes G; Rhein J; Meya DB; Boulware DR
    HIV Med; 2017 Jan; 18(1):13-20. PubMed ID: 27126930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cryptococcal antigenemia is associated with meningitis or death in HIV-infected adults with CD4 100-200 cells/mm
    Wykowski J; Galagan SR; Govere S; Wallis CL; Moosa MY; Celum C; Drain PK
    BMC Infect Dis; 2020 Jan; 20(1):61. PubMed ID: 31959112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood neutrophil counts in HIV-infected patients with cryptococcal meningitis: Association with mortality.
    Musubire AK; Meya DB; Rhein J; Meintjes G; Bohjanen PR; Nuwagira E; Muzoora C; Boulware DR; Hullsiek KH;
    PLoS One; 2018; 13(12):e0209337. PubMed ID: 30596708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Timing of antiretroviral therapy after diagnosis of cryptococcal meningitis.
    Boulware DR; Meya DB; Muzoora C; Rolfes MA; Huppler Hullsiek K; Musubire A; Taseera K; Nabeta HW; Schutz C; Williams DA; Rajasingham R; Rhein J; Thienemann F; Lo MW; Nielsen K; Bergemann TL; Kambugu A; Manabe YC; Janoff EN; Bohjanen PR; Meintjes G;
    N Engl J Med; 2014 Jun; 370(26):2487-98. PubMed ID: 24963568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV-Associated Cryptococcal Meningitis Occurring at Relatively Higher CD4 Counts.
    Tugume L; Rhein J; Hullsiek KH; Mpoza E; Kiggundu R; Ssebambulidde K; Schutz C; Taseera K; Williams DA; Abassi M; Muzoora C; Musubire AK; Meintjes G; Meya DB; Boulware DR;
    J Infect Dis; 2019 Feb; 219(6):877-883. PubMed ID: 30325463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cryptococcal meningitis in a tertiary hospital in Pretoria, mortality and risk factors - A retrospective cohort study.
    Hiesgen J; Schutte C; Olorunju S; Retief J
    Int J STD AIDS; 2017 Apr; 28(5):480-485. PubMed ID: 27255493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Glucuronoxylomannan-Associated Immune Signature, Characterized by Monocyte Deactivation and an Increased Interleukin 10 Level, Is a Predictor of Death in Cryptococcal Meningitis.
    Scriven JE; Graham LM; Schutz C; Scriba TJ; Wilkinson KA; Wilkinson RJ; Boulware DR; Urban BC; Lalloo DG; Meintjes G
    J Infect Dis; 2016 Jun; 213(11):1725-34. PubMed ID: 26768248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Independent association between rate of clearance of infection and clinical outcome of HIV-associated cryptococcal meningitis: analysis of a combined cohort of 262 patients.
    Bicanic T; Muzoora C; Brouwer AE; Meintjes G; Longley N; Taseera K; Rebe K; Loyse A; Jarvis J; Bekker LG; Wood R; Limmathurotsakul D; Chierakul W; Stepniewska K; White NJ; Jaffar S; Harrison TS
    Clin Infect Dis; 2009 Sep; 49(5):702-9. PubMed ID: 19613840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of therapeutic lumbar punctures on acute mortality from cryptococcal meningitis.
    Rolfes MA; Hullsiek KH; Rhein J; Nabeta HW; Taseera K; Schutz C; Musubire A; Rajasingham R; Williams DA; Thienemann F; Muzoora C; Meintjes G; Meya DB; Boulware DR
    Clin Infect Dis; 2014 Dec; 59(11):1607-14. PubMed ID: 25057102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cryptococcal meningitis in Lilongwe and Blantyre, Malawi.
    Maher D; Mwandumba H
    J Infect; 1994 Jan; 28(1):59-64. PubMed ID: 8163834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-dose amphotericin B with flucytosine for the treatment of cryptococcal meningitis in HIV-infected patients: a randomized trial.
    Bicanic T; Wood R; Meintjes G; Rebe K; Brouwer A; Loyse A; Bekker LG; Jaffar S; Harrison T
    Clin Infect Dis; 2008 Jul; 47(1):123-30. PubMed ID: 18505387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of cryptococcal meningitis in Uganda before and after the availability of highly active antiretroviral therapy.
    Kambugu A; Meya DB; Rhein J; O'Brien M; Janoff EN; Ronald AR; Kamya MR; Mayanja-Kizza H; Sande MA; Bohjanen PR; Boulware DR
    Clin Infect Dis; 2008 Jun; 46(11):1694-701. PubMed ID: 18433339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Asymptomatic cryptococcal antigenemia is associated with mortality among HIV-positive patients in Indonesia.
    Ganiem AR; Indrati AR; Wisaksana R; Meijerink H; van der Ven A; Alisjahbana B; van Crevel R
    J Int AIDS Soc; 2014; 17(1):18821. PubMed ID: 24476751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The spectrum of meningitis in a population with high prevalence of HIV disease.
    Bergemann A; Karstaedt AS
    QJM; 1996 Jul; 89(7):499-504. PubMed ID: 8759489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Asymptomatic serum cryptococcal antigenemia and early mortality during antiretroviral therapy in rural Uganda.
    Liechty CA; Solberg P; Were W; Ekwaru JP; Ransom RL; Weidle PJ; Downing R; Coutinho A; Mermin J
    Trop Med Int Health; 2007 Aug; 12(8):929-35. PubMed ID: 17697087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytomegalovirus Viremia Associated With Increased Mortality in Cryptococcal Meningitis in Sub-Saharan Africa.
    Skipper C; Schleiss MR; Bangdiwala AS; Hernandez-Alvarado N; Taseera K; Nabeta HW; Musubire AK; Lofgren SM; Wiesner DL; Rhein J; Rajasingham R; Schutz C; Meintjes G; Muzoora C; Meya DB; Boulware DR
    Clin Infect Dis; 2020 Jul; 71(3):525-531. PubMed ID: 31504335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of outcome in routine care for Cryptococcal meningitis in Western Kenya: lessons for HIV outpatient care in resource-limited settings.
    Kendi C; Penner J; Koech J; Nyonda M; Cohen CR; Bukusi EA; Ngugi E; Meyer AC
    Postgrad Med J; 2013 Feb; 89(1048):73-7. PubMed ID: 23112217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determinants of two-year mortality among HIV positive patients with Cryptococcal meningitis initiating standard antifungal treatment with or without adjunctive dexamethasone in Uganda.
    Kitonsa J; Nsubuga R; Mayanja Y; Kiwanuka J; Nikweri Y; Onyango M; Anywaine Z; Ggayi AB; Kibengo FM; Kaleebu P; Day J
    PLoS Negl Trop Dis; 2020 Nov; 14(11):e0008823. PubMed ID: 33253210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.